MCG Post Myocardial Infarction Study

NCT03358368 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-12-20

No results posted yet for this study

Summary

The study is being performed to evaluate a new portable medical device, the Creavo Vitalscan Magnetocardiograph (Vitalscan) on patients who have had a confirmed myocardial infarction (heart attack) within the previous 12 weeks.

Conditions

Interventions

DEVICE

Vitalscan

Vitalscan is a magnetocardiograph device

Sponsors & Collaborators

  • Creavo Medical Technologies Ltd

    lead INDUSTRY

Principal Investigators

  • Roger Beadle, MBBS · South Warwickshire NHS Foundation Trust, UK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-22
Primary Completion
2018-06-27
Completion
2018-08-10

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03358368 on ClinicalTrials.gov